Kaushik Chatterjee, Amit Kumar Dutta, Ashish Goel, Rekha Aaron, Vijayalekshmi Balakrishnan, Ajith Thomas, Anoop John, Rajeeb Jaleel, Deepu David, Reuben Thomas Kurien, S D Chowdhury, Ebby George Simon, A J Joseph, Prasanna Premkumar, Anna B Pulimood
{"title":"Common polymorphisms of protein tyrosine phosphate non-receptor type 2 gene are not associated with risk of Crohn's disease in Indian.","authors":"Kaushik Chatterjee, Amit Kumar Dutta, Ashish Goel, Rekha Aaron, Vijayalekshmi Balakrishnan, Ajith Thomas, Anoop John, Rajeeb Jaleel, Deepu David, Reuben Thomas Kurien, S D Chowdhury, Ebby George Simon, A J Joseph, Prasanna Premkumar, Anna B Pulimood","doi":"10.4291/wjgp.v13.i4.114","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Multiple genetic risk factors for Crohn's disease (CD) have been identified. However, these observations are not consistent across different populations. The protein tyrosine phosphate non-receptor type 2 (<i>PTPN2</i>) gene plays a role in various aspects of host defense including epithelial barrier function, autophagy, and innate and adaptive immune response. Two common polymorphisms in the <i>PTPN2</i> gene (rs2542151 and rs7234029) have been associated with risk of CD in Western countries.</p><p><strong>Aim: </strong>To evaluate the association of <i>PTPN2</i> gene polymorphisms with risk of CD in Indian population.</p><p><strong>Methods: </strong>We conducted a prospective case-control study. Patients with CD were recruited, and their clinical and investigation details were noted. Controls were patients without organic gastrointestinal disease or other comorbid illnesses. Two common polymorphisms in the <i>PTPN2</i> gene (rs2542151 and rs7234029) were assessed. DNA was extracted from peripheral blood samples of cases and controls and target DNA was amplified using specific sets of primers. The amplified fragments were digested with restriction enzymes and the presence of polymorphism was detected by restriction fragment length polymorphism. The frequency of alleles was determined. The frequencies of genotypes and alleles were compared between cases and controls to look for significant differences.</p><p><strong>Results: </strong>A total of 108 patients with CD (mean age 37.5 ± 12.7 years, females 42.6%) and 100 controls (mean age 39.9 ± 13.5 years, females 37%) were recruited. For the single nucleotide polymorphism (SNP) rs7234029, the overall frequency of G variant genotype (AG or GG) was noted to be significantly lower in the cases compared to controls (35.2% <i>vs</i> 50%, <i>P</i> = 0.05). For the SNP rs2542151, the overall frequency of G variant genotype (GT or GG) was noted to be similar in cases compared to controls (43.6% <i>vs</i> 47%, <i>P</i> = 0.73). There were no significant differences in minor allele (G) frequency for both polymorphisms between the cases and controls. Both the SNPs had no significant association with age of onset of illness, gender, disease location, disease behaviour, perianal disease, or extraintestinal manifestations of CD.</p><p><strong>Conclusion: </strong>Unlike observation form the West, polymorphisms in the <i>PTPN2</i> gene (rs7234029 and rs2542151) are not associated with an increased risk of developing CD in Indian patients.</p>","PeriodicalId":23760,"journal":{"name":"World Journal of Gastrointestinal Pathophysiology","volume":"13 4","pages":"114-123"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5c/70/WJGP-13-114.PMC9350595.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Gastrointestinal Pathophysiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4291/wjgp.v13.i4.114","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Multiple genetic risk factors for Crohn's disease (CD) have been identified. However, these observations are not consistent across different populations. The protein tyrosine phosphate non-receptor type 2 (PTPN2) gene plays a role in various aspects of host defense including epithelial barrier function, autophagy, and innate and adaptive immune response. Two common polymorphisms in the PTPN2 gene (rs2542151 and rs7234029) have been associated with risk of CD in Western countries.
Aim: To evaluate the association of PTPN2 gene polymorphisms with risk of CD in Indian population.
Methods: We conducted a prospective case-control study. Patients with CD were recruited, and their clinical and investigation details were noted. Controls were patients without organic gastrointestinal disease or other comorbid illnesses. Two common polymorphisms in the PTPN2 gene (rs2542151 and rs7234029) were assessed. DNA was extracted from peripheral blood samples of cases and controls and target DNA was amplified using specific sets of primers. The amplified fragments were digested with restriction enzymes and the presence of polymorphism was detected by restriction fragment length polymorphism. The frequency of alleles was determined. The frequencies of genotypes and alleles were compared between cases and controls to look for significant differences.
Results: A total of 108 patients with CD (mean age 37.5 ± 12.7 years, females 42.6%) and 100 controls (mean age 39.9 ± 13.5 years, females 37%) were recruited. For the single nucleotide polymorphism (SNP) rs7234029, the overall frequency of G variant genotype (AG or GG) was noted to be significantly lower in the cases compared to controls (35.2% vs 50%, P = 0.05). For the SNP rs2542151, the overall frequency of G variant genotype (GT or GG) was noted to be similar in cases compared to controls (43.6% vs 47%, P = 0.73). There were no significant differences in minor allele (G) frequency for both polymorphisms between the cases and controls. Both the SNPs had no significant association with age of onset of illness, gender, disease location, disease behaviour, perianal disease, or extraintestinal manifestations of CD.
Conclusion: Unlike observation form the West, polymorphisms in the PTPN2 gene (rs7234029 and rs2542151) are not associated with an increased risk of developing CD in Indian patients.
背景:克罗恩病(CD)的多种遗传危险因素已经确定。然而,这些观察结果在不同的人群中并不一致。蛋白酪氨酸磷酸非受体2型(PTPN2)基因在宿主防御的各个方面发挥作用,包括上皮屏障功能、自噬、先天和适应性免疫反应。PTPN2基因的两种常见多态性(rs2542151和rs7234029)与西方国家的CD风险相关。目的:探讨PTPN2基因多态性与印度人群患CD风险的关系。方法:我们进行了一项前瞻性病例对照研究。招募了乳糜泻患者,并记录了他们的临床和调查细节。对照组为无器质性胃肠道疾病或其他合并症的患者。评估了PTPN2基因的两个常见多态性(rs2542151和rs7234029)。从病例和对照组的外周血样本中提取DNA,并使用特定的引物扩增目标DNA。扩增后的片段用限制性内切酶酶切,用限制性内切片段长度多态性检测多态性的存在。测定等位基因的频率。比较病例与对照组的基因型和等位基因频率,寻找显著差异。结果:共招募了108例CD患者(平均年龄37.5±12.7岁,女性42.6%)和100例对照组(平均年龄39.9±13.5岁,女性37%)。对于单核苷酸多态性(SNP) rs7234029, G变异基因型(AG或GG)的总频率在病例中显著低于对照组(35.2% vs 50%, P = 0.05)。对于SNP rs2542151, G变异基因型(GT或GG)的总体频率在病例中与对照组相似(43.6% vs 47%, P = 0.73)。两种多态性的小等位基因(G)频率在病例和对照组之间无显著差异。这两个snp与发病年龄、性别、疾病部位、疾病行为、肛周疾病或CD的肠外表现均无显著相关性。结论:与西方观察结果不同,PTPN2基因(rs7234029和rs2542151)的多态性与印度患者发生CD的风险增加无关。